Covetrus (CVET) Gross Profit Margin starting from the second quarter 2022 to second quarter 2021, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Covetrus Inc.  (NASDAQ: CVET)


Covetrus's Gross Profit Margin by quarter

Trends, Rankings, Statistics



CVET Gross Profit Margin (Jun 30 2022)
Q2
(Mar 31 2022)
Q1
(Dec 31 2021)
Q4
(Sep 30 2021)
Q3
(Jun 30 2021)
Q2
Y / Y Revenue Change 2.35 %
Seq. Revenue Change 6.01 %
Revenue In Millions $1,217.00
Gross Profit Margin 18.82 %
Gross Profit Margin Total Ranking # 3416
Gross Profit In Millions $229.00
Y / Y Gross Profit Change 4.09 %
Seq. Gross Profit Change 1.78 %


Commenting Second Quarter 2022 Gross Profit Margin
Covetrus has managed to improve its Revenue sequentially to $1,217.00 millions by 6.01 % faster than Gross Profit increase of 1.78 % to $229.00 millions, this led to contraction in Gross Profit Margin to 18.82 %, but the Covetrus II. Quarter Gross Profit Margin remained above company average rate of 18.63%.


Observing second quarter 2022 results within Pharmacy Services & Retail Drugstore industry 12 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 3405 to 3416.
Learn about Gross Margin
CVET's Gross Profit Margin second quarter 2022 Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 13
Retail Sector # 176
Overall # 3347

Gross Profit Margin Statistics
High Average Low
19.6 % 18.63 % 17.5 %
(Mar 31 2022)   (Sep 30 2020)




Other Gross Profit Margin Profitability Ratios
CVET's Cumulative Gross Profit Margin
Pharmacy Services & Retail Drugstore Industry Gross Profit Margin Trends and Statistics
Retail Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
CVET's Gross Profit Margin Profitability versus Pharmacy Services & Retail Drugstore Industry, Retail Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for CVET's Competitors
Gross Profit Margin Profit Margin for Covetrus's Suppliers
Gross Profit Margin Profit Margin for CVET's Customers

You may also want to know
CVET's Annual Growth Rates CVET's Profitability Ratios CVET's Asset Turnover Ratio CVET's Dividend Growth
CVET's Roe CVET's Valuation Ratios CVET's Financial Strength Ratios CVET's Gross Profit Growth
CVET's Roa CVET's Inventory Turnover Ratio CVET's Growth Rates CVET's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2022, within Pharmacy Services & Retail Drugstore Industry Gross Profit MarginJun 30 2022 MRQ Gross ProfitJun 30 2022 MRQ Revenue
General Cannabis Corp  46.05 %$ 1.490  Millions$ 3.236  Millions
Medavail Holdings Inc   38.12 %$ 0.207  Millions$ 0.543  Millions
Zerostack Corp   37.11 %$ 3.319  Millions$ 8.943  Millions
Petmed Express Inc   28.41 %$ 19.943  Millions$ 70.187  Millions
Petiq Inc   24.59 %$ 61.974  Millions$ 252.014  Millions
Walgreens Boots Alliance Inc   20.16 %$ 6,572.000  Millions$ 32,597.000  Millions
Rite Aid Corp  19.90 %$ 1,196.729  Millions$ 6,014.583  Millions
Can B Corp   18.90 %$ 0.240  Millions$ 1.271  Millions
Covetrus Inc.  18.82 %$ 229.000  Millions$ 1,217.000  Millions
Cvs Health Corporation  17.04 %$ 13,740.000  Millions$ 80,636.000  Millions
Bimi International Medical Inc   16.71 %$ 0.473  Millions$ 2.829  Millions
Cosmos Health Inc   13.97 %$ 1.846  Millions$ 13.209  Millions
Merion Inc.  4.84 %$ 0.004  Millions$ 0.081  Millions
Mckesson Corporation  4.50 %$ 3,023.000  Millions$ 67,154.000  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.